TLR7 Expression is Decreased During Tumour Progression in Transgenic Adenocarcinoma of Mouse Prostate Mice and Its Activation Inhibits Growth of Prostate Cancer Cells

American Journal of Reproductive Immunology

Volumn 70, Issue 4, 2013, Pages 317-326

  Han, Ju Hee ^a   Park, Shin Young ^b   Kim, Jin Bum ^b   Cho, Sung Dae ^c   Kim, Bumseok ^c   Kim, Bo Yeon ^d   Kang, Min Jung ^b   Kim, Dong Jae ^b   Park, Jae Hak ^a   Park, Jong Hwan ^b,d  

^a University of Seoul   (South Korea)

^b Konyang University   (South Korea)

^c Chonbuk National University   (South Korea)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Colony formation; Growth inhibition; Prostate cancer; TLR7; Transgenic adenocarcinoma of mouse prostate mice

Indexed keywords

BETA INTERFERON; CRYSTAL VIOLET; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; INTERLEUKIN 6; LOXORIBINE; TOLL LIKE RECEPTOR 7;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL GROWTH; COLONY FORMATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; WESTERN BLOTTING;

COLONY FORMATION; GROWTH INHIBITION; PROSTATE CANCER; TLR7; TRANSGENIC ADENOCARCINOMA OF MOUSE PROSTATE MICE;

ADENOCARCINOMA; AMINOQUINOLINES; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOGENESIS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GUANOSINE; HUMANS; INFLAMMATION MEDIATORS; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PROSTATE; PROSTATIC NEOPLASMS; TOLL-LIKE RECEPTOR 7; TRANSGENES; TUMOR STEM CELL ASSAY;

EID: 84884209596     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12146     Document Type: Article

References (32)

1. Akira S, Uematsu S, Takeuchi O: Pathogen recognition and innate immunity. Cell 2006; 124:783-801.
2. Lee MS, Kim YJ: Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu Rev Biochem 2007; 76:447-480.
3. Rakoff-Nahoum S, Medzhitov R: Toll-like receptors and cancer. Nat Rev Cancer 2009; 9:57-63.
4. Wolska A, Lech-Maranda E, Robak T: Toll-like receptors and their role in carcinogenesis and anti-tumor treatment. Cell Mol Biol Lett 2009; 14:248-272.
5. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ: Cancer statistics, 2005. CA Cancer J Clin 2005; 55:10-30.
6. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG, Nakai Y, Isaacs WB, Nelson WG: Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007; 7:256-269.
7. Takeyama K, Mitsuzawa H, Shimizu T, Konishi M, Nishitani C, Sano H, Kunishima Y, Matsukawa M, Takahashi S, Shibata K, Tsukamoto T, Kuroki Y: Prostate cell lines secrete IL-8 in response to Mycoplasma hominis through Toll-like receptor 2-mediated mechanism. Prostate 2006; 66:386-391.
8. Kundu SD, Lee C, Billips BK, Habermacher GM, Zhang Q, Liu V, Wong LY, Klumpp DJ, Thumbikat P: The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells. Prostate 2008; 68:223-229.
9. Pei Z, Lin D, Song X, Li H, Yao H: TLR4 signaling promotes the expression of VEGF and TGFbeta1 in human prostate epithelial PC3 cells induced by lipopolysaccharide. Cell Immunol 2008; 254:20-27.
10. Hua D, Liu MY, Cheng ZD, Qin XJ, Zhang HM, Chen Y, Qin GJ, Liang G, Li JN, Han XF, Liu DX: Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity. Mol Immunol 2009; 46:2876-2884.
11. Di JM, Pang J, Pu XY, Zhang Y, Liu XP, Fang YQ, Ruan XX, Gao X: Toll-like receptor 9 agonists promote IL-8 and TGF-beta1 production via activation of nuclear factor kappaB in PC-3 cells. Cancer Genet Cytogenet 2009; 192:60-67.
12. Paone A, Starace D, Galli R, Padula F, De Cesaris P, Filippini A, Ziparo E, Riccioli A: Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism. Carcinogenesis 2008; 29:1334-1342.
13. Schon MP, Schon M: TLR7 and TLR8 as targets in cancer therapy. Oncogene 2008; 27:190-199.
14. Kawai T, Akira S: Innate immune recognition of viral infection. Nat Immunol 2006; 7:131-137.
15. Miller R, Gerster J, Owens M, Slade H, Tomai M: Review article Imiquimod applied topically: a novel immune response modifier and new class of drug. Int J Immunopharmacol 1999; 21:1-14.
16. Huang S-W, Chang C-C, Lin C-C, Tsai J-J, Chen Y-J, Wu C-Y, Liu K-T, Shieh J-J: Mcl-1 determines the imiquimod-induced apoptosis but not imiquimod-induced autophagy in skin cancer cells. J Dermatol Sci 2012; 65:170-178.
17. Gorden KB, Gorski KS, Gibson SJ, Kedl RM, Kieper WC, Qiu X, Tomai MA, Alkan SS, Vasilakos JP: Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J Immunol 2005; 174:1259-1268.
18. Heil F, Ahmad-Nejad P, Hemmi H, Hochrein H, Ampenberger F, Gellert T, Dietrich H, Lipford G, Takeda K, Akira S: The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur J Immunol 2003; 33:2987-2997.
19. Greenberg N, DeMayo F, Finegold M, Medina D, Tilley W, Aspinall J, Cunha G, Donjacour A, Matusik R, Rosen J: Prostate cancer in a transgenic mouse. Proc Natl Acad Sci U S A 1995; 92:3439.
20. Smith EB, Schwartz M, Kawamoto H, You X, Hwang D, Liu H, Scherr DS: Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder. J Urol 2007; 177:2347-2351.
21. Pawar RD, Patole PS, Zecher D, Segerer S, Kretzler M, Schlöndorff D, Anders H-J: Toll-like receptor-7 modulates immune complex glomerulonephritis. J Am Soc Nephrol 2006; 17:141-149.
22. Galli R, Starace D, Busa R, Angelini DF, Paone A, De Cesaris P, Filippini A, Sette C, Battistini L, Ziparo E, Riccioli A: TLR stimulation of prostate tumor cells induces chemokine-mediated recruitment of specific immune cell types. J Immunol 2010; 184:6658-6669.
23. Konig JE, Senge T, Allhoff EP, Konig W: Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer. Prostate 2004; 58:121-129.
24. Elkahwaji JE, Zhong W, Hopkins WJ, Bushman W: Chronic bacterial infection and inflammation incite reactive hyperplasia in a mouse model of chronic prostatitis. Prostate 2007; 67:14-21.
25. Elkahwaji JE, Hauke RJ, Brawner CM: Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate. Br J Cancer 2009; 101:1740-1748.
26. Chin AI, Miyahira AK, Covarrubias A, Teague J, Guo B, Dempsey PW, Cheng G: Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance. Cancer Res 2010; 70:2595-2603.
27. Samara KD, Antoniou KM, Karagiannis K, Margaritopoulos G, Lasithiotaki I, Koutala E, Siafakas NM: Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis. Int J Oncol 2012; 40:1397-1404.
28. Cherfils-Vicini J, Platonova S, Gillard M, Laurans L, Validire P, Caliandro R, Magdeleinat P, Mami-Chouaib F, Dieu-Nosjean MC, Fridman WH, Damotte D, Sautes-Fridman C, Cremer I: Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance. J Clin Invest 2010; 120:1285-1297.
29. Sheyhidin I, Nabi G, Hasim A, Zhang RP, Ainiwaer J, Ma H, Wang H: Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma. World J Gastroenterol 2011; 17:3745-3751.
30. Ochi A, Graffeo CS, Zambirinis CP, Rehman A, Hackman M, Fallon N, Barilla RM, Henning JR, Jamal M, Rao R, Greco S, Deutsch M, Medina-Zea MV, Bin Saeed U, Ego-Osuala MO, Hajdu C, Miller G: Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans. J Clin Invest 2012; 122:4118-4129.
31. Eiro N, Gonzalez L, Gonzalez LO, Andicoechea A, Fernandez-Diaz M, Altadill A, Vizoso FJ: Study of the expression of toll-like receptors in different histological types of colorectal polyps and their relationship with colorectal cancer. J Clin Immunol 2012; 32:848-854.
32. Andreani V, Gatti G, Simonella L, Rivero V, Maccioni M: Activation of Toll-like receptor 4 on tumor cells in vitro inhibits subsequent tumor growth in vivo. Cancer Res 2007; 67:10519-10527.